D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ALGS holding history
Aligos Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALGS overviewAll 13F holders of ALGSFull Q2 2026 holdings
- Shares (Q2 2026)
- 66,463
- Value
- $383.5K
- % of portfolio
- <0.1%
- Quarters held
- 5
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 66,463 | $383.5K | <0.1% | +55,485+505.4% | Added | Holders |
| Q1 2026 | 10,978 | $81.6K | <0.1% | +10,978 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −31,568−100.0% | Sold out | Holders |
| Q3 2022 | 31,568 | $35.0K | <0.1% | −123,300−79.6% | Reduced | Holders |
| Q2 2022 | 154,868 | $187.0K | <0.1% | +134,098+645.6% | Added | Holders |
| Q1 2022 | 20,770 | $45.0K | <0.1% | +20,770 | New | Holders |